Toward broader inclusion of liquid chromatography-mass spectrometry in the clinical laboratory

Clinical Chemistry

Volumn 50, Issue 9, 2004, Pages 1500-1502

  Kinter, Michael ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ESTRADIOL; ESTRONE; HOMOCYSTEINE; PREALBUMIN;

BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CLINICAL LABORATORY; DNA SEQUENCE; DRUG MONITORING; EDITORIAL; ELECTROSPRAY; ENDOCRINE FUNCTION TEST; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FERTILITY; INTERMETHOD COMPARISON; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; MOLECULAR WEIGHT; OPTICAL RESOLUTION; PROTEIN ANALYSIS; PROTEIN ISOLATION; QUADRUPOLE MASS SPECTROMETRY; TISSUE INJURY;

CHEMISTRY, CLINICAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 4344696084     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.037523     Document Type: Editorial

References (15)

1. Nepomuceno AI, Mason CJ, Muddiman DC, Bergen HR III, Zeldenrust SR. Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry. Clin Chem 2004;50:1535-43.
2. Bergen HR III, Zeldenrust SR, Butz ML, Snow DS, Dyck PJ, Dyck JB, et al. Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin Chem 2004;50:1544-52.
3. Hannis JC, Muddiman DC. A dual electrospray ionization source combined with hexapole accumulation to achieve high mass accuracy of biopolymers in Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2000;11:876-83.
4. Tannen H, Mohring T, Kellmann M, Pich A, Kreipe HH, Hess R. Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display. Clin Chem 2004;50:545-51.
5. Arndt T, Guessregen B, Hohl A, Heicke B. Total plasma homocysteine measured by liquid chromatography-tandem mass spectrometry with use of 96-well plates. Clin Chem 2004;50:755-7.
6. Stabler S, Allen RH. Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. Clin Chem 2004;50:365-72.
7. Nelson RE, Grebe SK, O'Kane DJ, Singh RJ. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;50:373-84.
8. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid cnromatograpny-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem 2004;50:152-9.
9. Whitehouse CM, Dreyer RN, Yamashita M, Fenn JB. Electrospray interface for liquid chromatographs and mass spectrometers. Anal Chem 1985;57:675-9.
10. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
11. Kinter M. Clinical chemistry, mass spectrometry. Anal Chem 1995;67:493R-7R.
12. Srinivas PR, Verma M, Zhao Y, Srivastava S. Proteomics for cancer biomarker discovery. Clin Chem 2002;48:1160-9.
13. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 2003;289:1675-80.
14. Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J, et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents In malignant vs nonmalignant ascitic fluids. Anal Biochem 2001;290:302-13.
15. Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP, et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004;in press.